Obesity research continues to spring leaks
- Market savvy. Horton, Kathleen // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p158
Focuses on the report `Therapeutic Approaches to the Treatment of Obesity,' which examines the market conditions for weight-reducing pharmaceuticals. Key issues in developing novel anti-obesity agents; Other contents of the report; Contact information.
- Back to basics: Three squares a day. // Environmental Nutrition;Nov92, Vol. 15 Issue 11, p3
Reports that the best way to lose weight is to go back to eating three square meals a day instead of skipping meals or eating five to six small meals a day. Effects of skipping meals; Small meals.
- Weight loss for obese people: What works? // HealthFacts;Jan97, Vol. 22 Issue 1, p3
Focuses on the declaration of obesity as a chronic disease to be treated with drugs. Results of a review of studies in which participants underwent drug and/or behavioral therapy; Warning against people embarking on drug therapy; Potential side effects.
- An up-and-coming drug for the obese. // Modern Medicine;Jan96, Vol. 64 Issue 1, p33
Reports on the US Food and Drug Administration's (FDA) approval of an anti-obesity drug which is used in 65 other countries. Drug composition; Effectiveness.
- New obesity drug should be reserved for patients who reach a plateau or who have trouble... // Modern Medicine;Jun96, Vol. 64 Issue 6, p14
Reports on a drug called dexfenfluramine hydrochloride claimed to be effective for the treatment of obesity. Reduction of weight in obese patients who have reached a plateau in their weight; Clinical studies on the drug; Effectiveness of the drug; Recommended dosage of the drug.
- First new drug in 20 years to help fight obesity. // Modern Medicine;Jun96, Vol. 64 Issue 6, p40
Reports on a drug called dexfenfluramine hydrochloride claimed to be effective in the treatment of pathological obesity. Promotion of weight loss; Maintenance of weight loss; Recommendation for patients with chronic diseases such as diabetes, hypertension and hypercholesterolemia.
- Drug treatment for obesity. Berg, Frances M. // Obesity & Health;Jan/Feb93, Vol. 7 Issue 1, p8
Reports how an intense search is on for drug solutions to the problems of obesity, through research at numerous academic and commercial laboratories in many countries. What the ideal drug should do; How only appetite suppressant drugs are available on the market; Serotonergic agents;...
- Problem-solving skills improve maintenance after weight loss. Berg, Frances M. // Obesity & Health;Jul/Aug93, Vol. 7 Issue 4, p68
Reports on a California study that shows women using similar strategies, but in ways specific to their own lifestyle, as able to maintain weight loss of 20 pounds for two years. Maintainers, regainers and controls categories; Maintenance strategies; Differences between maintainers and...
- Inhibiting fat storage. // Obesity & Health;Sep/Oct93, Vol. 7 Issue 5, p86
Looks at the work of researchers in the Netherlands who found that excessive body fat comes almost exclusively from dietary fat. Test of the effects of Orlistat, an inhibitor of intestinal fat absorption; Details of the study.
- The treatment of obesity: Facilitate without harm. // Obesity & Health;Sep/Oct93, Vol. 7 Issue 5, p92
Presents an excerpt from the Timely Statement on The Treatment of Obesity, which was issued April 28, 1992 by the Corporation professionnelle des dietetistes du Quebec. Advice on how to help individuals reach and/or maintain a healthy weight; More.